Author

Alba Cabaleiro

Universidade de Santiago de Compostela

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alejandro Fuentes-IglesiasiD· 1 shared Alfonso MoraiD· 1 shared Ana T. MaduroiD· 1 shared Anxo VidaliD· 1 shared Carlos DiégueziD· 1 shared Carmen Quintela-VilariñoiD· 1 shared Cristina RiobelloiD· 1 shared Diana GuallariD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Alejandro Fuentes-IglesiasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of p107 alleviates liver steatosis by reducing de novo fatty acid synthesis.

Juan Cuñarro, Marta Varela Miguens, Tadeu de Oliveira Diz, Xabier Buqué, Lucia Oro, Cristina Riobello, Jose Iglesias-Moure, Carmen Quintela-Vilariño, Ana T. Maduro, Alba Cabaleiro, Eva Nóvoa, Alejandro Fuentes-Iglesias, Miguel Fidalgo, Diana Guallar, Anxo Vidal, , Sulay A. Tovar

This study shows that inhibiting p107 reduces liver steatosis by lowering de novo fatty acid synthesis and enhancing mitochondrial function in both mouse models and human hepatocytes.

bioRxiv · Apr 16, 2026 · PreprintPhysiology